Non-Steroidal Aromatase Inhibitor (AI)
Active Substance: Letrozole
Manufacturer: British Dragon
Unit: 100 Tablets (2.5 mg/tablet)
Form: Oral Tablets
USA Domestic: 2–7 Days Delivery
International: 5–20 Days Delivery
Letrobol 2.5 mg by British Dragon is a pharmaceutical-grade oral aromatase inhibitor containing Letrozole, one of the most potent non-steroidal AIs available. It is primarily used by experienced athletes and bodybuilders who require aggressive estrogen suppression in specific situations, such as severe estrogen rebound, high-dose aromatizing cycles, or estrogen-related complications that do not respond adequately to milder AIs.
Unlike compounds such as Anastrozole or Exemestane, Letrozole is not typically used for routine estrogen management. Its strength makes it better suited for short-term, targeted use where precise control is required rather than continuous long-term dosing.
Each tablet contains 2.5 mg of Letrozole. British Dragon manufactures Letrobol under controlled conditions to ensure accurate dosing, consistent potency, and predictable pharmacological behavior.
Letrozole is clinically classified as a non-steroidal aromatase inhibitor. In medical contexts, it is used in estrogen-dependent conditions. In performance-enhancement environments, it is used off-label for short-term estrogen control when milder options are insufficient. Detailed pharmacological information on Letrozole can be reviewed via the National Library of Medicine (PubMed).
Due to its potency, Letrozole is typically introduced conservatively and used only when clearly indicated. Many experienced users employ fractional dosing strategies rather than daily full-tablet use. Blood work is strongly advised before, during, and after use.
Use in women should only occur under professional supervision. Hormonal suppression from Letrozole can be profound and unpredictable.
Letrozole has a long functional half-life of approximately 2–4 days, meaning estrogen suppression can persist well beyond the last dose. This is why careful spacing and short-term use are emphasized.
Potential side effects include joint dryness, fatigue, low libido, mood changes, and symptoms associated with excessively low estrogen. These effects are more likely if Letrozole is overused or misapplied.
Not recommended for beginners or routine cycle use. Avoid prolonged use without monitoring. Excessive estrogen suppression may negatively impact joints, cardiovascular health, and overall well-being.
Overuse can result in near-complete estrogen suppression, leading to significant discomfort and hormonal imbalance. Always err on the side of minimal effective exposure.
Letrobol is most commonly introduced in advanced cycles involving highly aromatizing compounds such as Andropen 450 or heavy testosterone bases like Testabol Enanthate. Some experienced users transition to milder AIs or SERMs such as Tamoxifen once estrogen levels are stabilized.
Letrobol is supplied as 100 oral tablets (2.5 mg/tablet), securely packaged by British Dragon to maintain stability and dosage accuracy.
Store in a cool, dry place away from light and moisture. Keep out of reach of children.
Letrobol is frequently referenced in advanced bodybuilding discussions as a last-line estrogen management option rather than a first-choice AI.
It is used for aggressive, short-term estrogen suppression in advanced cycle scenarios.
Yes. Letrozole is significantly more potent and is not intended for routine estrogen control.
It is generally avoided for full-cycle use due to the risk of excessive estrogen suppression.
No. Letrobol is intended for experienced users with clear estrogen-management needs.
British Dragon is a long-standing manufacturer known for consistent pharmaceutical-grade products.
Please log in to write Letrobol 2.5 mg (100 Tabs) review.